CBAS180 De-escalation Study

NARecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

February 19, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

January 15, 2026

Conditions
Barrett's EsophagusAblation TherapyCryotherapyCryoballoon Ablation
Interventions
DEVICE

C2 CryoBalloon 180° Ablation System

The C2 CryoBalloon 180° Ablation System is a cryosurgical device with a nitrous oxide cooled balloon probe that is compatible with upper gastrointestinal therapeutic endoscopes.

Trial Locations (6)

Unknown

RECRUITING

Catharina Hospital, Eindhoven

RECRUITING

Amsterdam UMC, Amsterdam

RECRUITING

UMC Groningen, Groningen

RECRUITING

Erasmus MC, Rotterdam

RECRUITING

St Antonius hospital, Nieuwegein

RECRUITING

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pentax Medical

INDUSTRY

lead

Koen Munters

OTHER

NCT05740189 - CBAS180 De-escalation Study | Biotech Hunter | Biotech Hunter